NCT04185701

Brief Summary

Main objective Show that the equivalent sphere refraction measurements obtained by the SiVIEW software have no significant clinical difference with those obtained by an optometrist expert. Secondary objectives Show that the sphere refraction measurements obtained by the SiVIEW software have no significant clinical difference with those obtained by an optometrist expert. Show that the cylinder refraction measurements obtained by the SiVIEW software have no significant clinical difference with those obtained by an optometrist expert. Show that the visual acuity measurements obtained by the SiVIEW software do not have a significant clinical difference with those obtained by an optometrist expert. Demonstrate that the report delivered for each eye exam by SiVIEW software is consistent and relevant to a vision health practitioner. Show that the differences obtained between two eye examination experts are consistent with those found in the literature.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
111

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 30, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 4, 2019

Completed
2.9 years until next milestone

Study Start

First participant enrolled

November 1, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2023

Completed
Last Updated

November 24, 2023

Status Verified

March 1, 2023

Enrollment Period

8 months

First QC Date

November 30, 2019

Last Update Submit

November 21, 2023

Conditions

Keywords

automatic sphere measurementseye examinationametropia

Outcome Measures

Primary Outcomes (1)

  • Equivalent sphere measurement

    The subject will have an eye exam with SiVIEW and an examination by an optometrist expert. The equivalent sphere value will be evaluated in both cases.

    At time of inclusion

Secondary Outcomes (5)

  • Sphere measurement

    At time of inclusion

  • Cylinder measurement

    At time of inclusion

  • Visual acuity

    At time of inclusion

  • Consistency and relevance of the SiVIEW report

    At time of inclusion

  • Measurement between two optometrist experts

    At time of inclusion

Study Arms (1)

Eye examination by expert and SiVIEW software

EXPERIMENTAL

Eye examination by an expert and by a technician with the SiVIEW system.

Other: SiVIEW softwareOther: Expert

Interventions

Eye examination by a technician with the SiVIEW software

Eye examination by expert and SiVIEW software
ExpertOTHER

Eye examination by an expert including optimal correction in distance and near vision

Eye examination by expert and SiVIEW software

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • subject with visual AV on each eye \>= 8/10 and no amblyopia
  • subject with normal environmental transparency
  • subject with a healthy fundus that does not reveal major abnormalities that may affect vision
  • subject able to read the letters of the Latin alphabet
  • subject without heavy drug treatment that may affect vision as synthetic antimalarials, corticosteroids
  • non-diabetic subject
  • non nystagmic subject
  • non-strabic subject
  • subject who has not had eye surgery less than 1 year old

You may not qualify if:

  • subject with a topography showing an anomaly (keratoconus type or other)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ophthalmological Foundation A. de Rothschild

Paris, France

Location

MeSH Terms

Conditions

Eye DiseasesRefractive Errors

Study Officials

  • Damien Gatinel, MD

    Head of Department Ophthalmological Foundation A. de Rothschild, Paris, France

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SEQUENTIAL
Model Details: * Eye examination by an expert including optimal correction in distance and near vision * Eye examination by a technician with the SiVIEW system * Analysis of the SiVIEW report by the expert who conducted the second review
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 30, 2019

First Posted

December 4, 2019

Study Start

November 1, 2022

Primary Completion

June 15, 2023

Study Completion

June 15, 2023

Last Updated

November 24, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations